Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma
Guillermo de Velasco, Kathryn P. Gray, Lana Hamieh, Yuksel Urun, Hallie A. Carol, Andre P. Fay, Sabina Signoretti, David J. Kwiatkowski, David F. McDermott, Matthew Freedman, Mark M. Pomerantz, Toni K. Choueiri
Dive into the research topics of 'Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma'. Together they form a unique fingerprint.